Monitoring antibody titers to recombinant core-NS3 fusion polypeptide is useful for evaluating hepatitis C virus infection and responses to interferon-alpha therapy

Journal of Korean Medical Science

Volumn 14, Issue 2, 1999, Pages 165-170

  Park, Young Min ^a,b,c   Byun, Byung Hun ^a,b,c   Choi, Jong Young ^a,b,c   Bae, Si Hyun ^a,b,c   Kim, Boo Sung ^a,c   So, Hong Soeb ^d   Ryu, Wang Shick ^e  

^a The Catholic University of Korea   (South Korea)

^b The Catholic University of Korea   (South Korea)

^c The Catholic University of Korea   (South Korea)

^d LG Chemical Ltd   (South Korea)

^e Yonsei University   (South Korea)

Author keywords

Hepatitis C antibodies; Hepatitis C like viruses; Viral fusion proteins

Indexed keywords

ALPHA2A INTERFERON; CORE PROTEIN; HEPATITIS C ANTIBODY; HEPATITIS C ANTIGEN; HYBRID PROTEIN; NS3 PROTEIN, HEPATITIS C VIRUS; NUCLEOCAPSID PROTEIN, HEPATITIS C VIRUS; VIRUS PROTEIN; VIRUS RNA;

ADULT; AGED; ARTICLE; BLOOD; FEMALE; GENETICS; GENOTYPE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; IMMUNOBLOTTING; IMMUNOLOGY; MALE; MIDDLE AGED;

ADULT; AGED; FEMALE; GENOTYPE; HEPACIVIRUS; HEPATITIS C; HEPATITIS C ANTIBODIES; HEPATITIS C ANTIGENS; HUMANS; IMMUNOBLOTTING; INTERFERON ALFA-2A; MALE; MIDDLE AGED; RECOMBINANT FUSION PROTEINS; RNA, VIRAL; VIRAL CORE PROTEINS; VIRAL NONSTRUCTURAL PROTEINS;

EID: 0033111916     PISSN: 10118934     EISSN: None     Source Type: Journal    
DOI: 10.3346/jkms.1999.14.2.165     Document Type: Review

References (27)

1. Dienstag JL. Non-A, non-B hepatitis. Recognition, epidemiology, and clinical features. Gastroenterology 1983; 85: 439-62.
2. Alter HJ and Seeff LB. Transfusion-associated hepatitis. In: Zuckerman AJ, Thomas HC, editors. Viral Hepatitis: Scientific Basis and Clinical Management. Edinburgh: Churchill Livingstone, 1993: 467-99.
3. Choo Q-L, Kuo G, Weiner AJ, Overby LR, Bradley DW, Houghton M. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science 1989; 244: 359-62.
4. Kuo G, Choo Q-L, Alter HJ, Gitnick GL, Redeker AG, Purcell RH, Miyamura T, Dienstag JL, Alter MJ, Stevens CE, Tegtmeier GE, Bonino F, Colombo M, Lee WS, Kuo C, Berger K, Schuster JR, Overby LR, Bradley DW, Houghton M. An assay for circulating antibodies to a major etiologic agent of human non-A, non-B hepatitis. Science 1989; 244: 362-4.
5. De Medina M, Schiff ER. Hepatitis C virus: diagnostic assays. Sem Liv Dis 1995; 15: 33-40.
6. Okamoto H, Okada S, Sugiyama Y, Tanaka T, Sugai Y, Akahane Y, Machida A, Mishiro S, Yoshizawa H, Miyakawa Y. Detection of hepatitis C virus RNA by a two-stage polymerase chain reaction with two pairs of primers deduced from the 5′-noncoding region. Jpn J Exp Med 1990; 60: 215-22.
7. Zaaijer HL, Cuypers HT, Reesink HW, Winkel IN, Gerken G, Lelie PN. Reliability of polymerase chain reaction for detection of hepatitis C virus. Lancet 1993; 341: 722-4.
8. Urdea MS. Branched DNA signal amplification. Bio/Technology 1994; 12: 926-7.
9. Zaaijer HL, Vrielink H, van Exel-Oehlers PJ, Cuypers HT, Lelie PN. Confirmation of hepatitis C infection: a comparison of five immunoblot assays. Transfusion 1994; 34: 603-7.
10. Nakano Y, Kiyosawa K, Sodeyama T, Tanaka E, Yoshizawa K, Furuta K, Kakatsuji Y, Urushihara A, Furuta S. Anti-c100 antibodies to hepatitis C virus in patients with chronic hepatitis C virus infection treated with interferon. Scand J Gastroenterol 1993; 28: 335-42.
11. Li XM, Reddy KR, Jeffers LJ, Parker T, de Medina M, Schiff ER. Indeterminate hepatitis C. Lancet 1993; 341: 835.
12. Yoo DG, Kim BS. Serological survey of hepatitis B virus related anti-core, anti-NS-3, anti-NS-4, and anti-NS-5 antibodies for non-A, non-B liver diseases. J Catholic Medical College 1992; 45: 805-12.
13. Kim DW, Kwon SW, Chi HS, Kim IS. Evaluation of the third-generation enzyme immunoassay and confirmatory test for anti-HCV. Korean J Blood Transfus 1994; 5: 115-26.
14. Cho JM, Park Y-W, Lee Y-B, Yang J-Y, Kim C-H, Choo S-H, Ryu W-S. Molecular cloning of hepatitis C virus genome from a single Korean blood donor. Mol Cells 1995; 5: 317-24.
15. Kim C-J, Shin K-S, Kim W-Y, Lim D-S, Yoon S-K, Park Y-M, Kim B-S, Jang S-K, Cho M-J. Genotype distribution and comparison of the putative envelope region of hepatitis C virus from Korean patients. J Med Virol 1995; 46: 380-6.
16. Yoon S-K, Kim SS, Park YM, Shim KS, Lee CD, Sun HS, Park DH, Kim BS, Ryu WS, Cho JM. Predictive factors for beneficial response to interferon-alfa therapy in chronic hepatitis C. Korean J Internal Med 1995; 10: 94-102.
17. Simmonds P, Holmes EC, Cha TA, Chan SW, McOmish F, Irvine B, Beall E, Yap PL, Kolberg J, Urdea MS. Classification of hepatitis C virus into six major genotypes and a series of subtypes by phylogenetic analysis of the NS-5 region. J Gen Virol 1993; 74: 2391-9.
18. Brillanti S, Masci C, Ricci P, Miglioli M, Barbara L. Significance of IgM antibody to hepatitis C virus in patients with chronic hepatitis C. Hepatology 1992; 15: 998-1001.
19. Tanaka E, Kiyosawa K, Nakatsuji Y, Inoue Y, Miyamura T, Chiba J, Furuta S. Clinical significance of antibodies to nonstructural and core proteins of hepatitis C virus in posttransfusion hepatitis patients during long-term follow-up. J Med Virol 1993; 39: 318-24.
20. Hellstrom UB, Sylvan SPE, Decker RH, Sonnerberg A. Immunoglobulin M reactivity towards the immunologically active region sp75 of the core protein of hepatitis C virus (HCV) in chronic HCV infection. J Med Virol 1993; 39: 325-32.
21. Urushihara A, Suzuki T, Matsumoto A, Tanaka E, Sodeyama U, Kiyosawa K, Furuta S. Quantitative assay for anti-HCV-core antibody in healthy individuals found anti-HCV positive during a mass screening. Int Hepatol Comm 1994; 2: 47-51.
22. Nagayama R, Miyake K, Tsuda F, Okamoto H. IgM antibody to a hepatitis C virus core peptide (CP14) for monitoring activity of liver disease in patients with acute or chronic hepatitis C. J Med Virol 1994; 42: 311-7.
23. Sato A, Nakamura H, Sho Y, Arima T. Quantitation of anti-hepatitic C virus antibodies in interferon-treated patients by S29-1/S4 ELISA. J Med Virol 1995; 47: 226-30.
24. Lesniewski R, Okasinski G, Carrick R, Van Sant C, Desi S, Johnson R, Scheffel J, Moore M, Mushahwar I. Antibody to hepatitis C virus second envelop (HCV-E2) glycoprotein: A new marker of HCV infection closely associated with viremia. J Med Virol 1995; 45: 415-22.
25. Taura Y, Fujiyama S, Kawano S, Sato S, Goto M, Chikazawa H, Shibata J, Mizuno K, Sato T. Titration of antibody against hepatitis C virus core protein and its clinical utility. J Hepatol 1993; 18: 138-9.
26. Yuki N, Hayashi N, Hagiwara H, Takehara T, Katayama K, Kasahara A, Fusamoto H, Kamada T. Quantitative analysis of antibodies to hepatitis C virus during interferon-α therapy. Hepatology 1993; 17: 960-5.
27. Kawano S, Tanaka M, Fujiyama S, Sato S, Taura Y, Goto M, Chikazawa H, Sato T. Clinical usefulness of an assay for hepatitis C virus core in the diagnosis of non-A, non-B hepatitis and monitoring of the response to interferon therapy. J Gastroenterol Hepatol 1994; 9: 217-22.